Bora Pharmaceuticals set to shake up rare disease treatment with Pyros Pharmaceuticals acquisition

Bora Pharmaceuticals Co., Ltd. is intensifying its presence in the rare disease treatment market by acquiring U.S.-based Pyros Pharmaceuticals, a company focused on specialized rare ... Read More